The transition to Schizophrenia spectrum disorder from a first psychotic episode that did or did not appear to be induced by substance use.


Journal

Psychiatry research
ISSN: 1872-7123
Titre abrégé: Psychiatry Res
Pays: Ireland
ID NLM: 7911385

Informations de publication

Date de publication:
10 2023
Historique:
received: 01 08 2022
revised: 08 09 2023
accepted: 09 09 2023
medline: 3 10 2023
pubmed: 16 9 2023
entrez: 15 9 2023
Statut: ppublish

Résumé

The first years following a first-episode psychosis (FEP) are crucial. This retrospective cohort study investigates the evolution of first-episode psychosis (FEP), including substance-induced psychosis (SIP), and explores factors influencing the diagnostic conversion to Schizophrenia or Schizophrenia Spectrum Disorders (SSD). Diagnoses of patients discharged from Basurto University Hospital's inpatient psychiatry unit between January 2002 and December 2016 were reviewed. Sociodemographic, clinical, and substance use data, including cannabinoids, opioids, amphetamines, cocaine, and alcohol, were collected. The analysis utilized descriptive statistics, Kaplan-Meier survival curves, and Cox regression. Among 341 patients, 64.8% were male, with a mean age of 33.8 years. Psychiatric family history was present in 33.4% of cases, and cannabis was the most commonly used substance (78.9%). Of the patients, 52.8% received subsequent diagnoses of Schizophrenia or SSD, with 86.9% of these cases occurring within the first five years. No significant differences were observed between patients diagnosed with SIP and other diagnoses in terms of sociodemographic, clinical characteristics, or progression to Schizophrenia or SSD. However, use of cannabis (compared to use of another substance or polysubstance use) was associated with a higher risk to conversion (HR 1.96; p = 0.001). These findings underscore the importance of addressing substance use and treatment adherence in FEP.

Identifiants

pubmed: 37713923
pii: S0165-1781(23)00425-0
doi: 10.1016/j.psychres.2023.115475
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

115475

Informations de copyright

Copyright © 2023. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no conflict of interest.

Auteurs

Lucía Inchausti (L)

University of the Basque Country-Euskal Herriko Unibertsitatea, Neuroscience Department, Leioa, Spain; Osakidetza, Basurto University Hospital, Psychiatric Department, Bilbao, Spain; Biocruces Bizkaia, Mental Health Research Group, Barakaldo, Spain; Centro de Investigación en Red de Salud Mental. (CIBERSAM), Instituto de Salud Carlos III. Electronic address: lucia.inchaustilopezlarrucea@osakidetza.eus.

Inigo Gorostiza (I)

Osakidetza, Basurto University Hospital, Research Unit, Bilbao, Spain; REDISSEC (Spanish Research Network in Chronic Disease Health Services), Madrid, Spain.

Miguel Angel Gonzalez Torres (MA)

University of the Basque Country-Euskal Herriko Unibertsitatea, Neuroscience Department, Leioa, Spain; Osakidetza, Basurto University Hospital, Psychiatric Department, Bilbao, Spain; Biocruces Bizkaia, Mental Health Research Group, Barakaldo, Spain; Centro de Investigación en Red de Salud Mental. (CIBERSAM), Instituto de Salud Carlos III.

Rodrigo Oraa (R)

Osakidetza, Mental Health Network of Bizkaia, Ajuriaguerra Mental Health Centre - Addictions Manuene Day Hospital, Bizkaia, Spain; Biocruces Bizkaia, Mental Health Network, Barakaldo, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH